v3.10.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 29, 2018
Dec. 30, 2017
Dec. 31, 2016
Cash flows from operating activities      
Net earnings $ 126,224 $ 62,535 $ 100,041
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities      
Depreciation and amortization 16,843 16,110 13,482
(Gain) loss on sale of property and equipment 1,805 18 116
Equity-based compensation expense 14,955 15,482 16,542
Deferred income taxes 699 19,306 (3,700)
(Gain) loss on impairment on note receivable (658) 2,734  
Changes in operating assets and liabilities:      
Inventories (23,101) 6,054 (1,034)
Prepaid expenses and other assets (1,626) 5,010 (9,749)
Accounts payable (1,720) 3,043 (1,341)
Other liabilities 18,698 (6,518) 22,534
Net cash provided by (used in) operating activities 152,119 123,774 136,891
Cash flows from investing activities      
Additions to notes receivable     (7)
Receipts on notes receivable 4,849 296 811
Proceeds from the settlement of net investment hedges 739    
Purchases of investment securities held-to-maturity (86,396)    
Maturities of investment securities 22,857    
Proceeds from sale of property and equipment 381 22 11
Purchases of property and equipment (11,433) (13,220) (32,698)
Net cash provided by (used in) investing activities (69,003) (12,902) (31,883)
Cash flows from financing activities      
Repurchase of common stock (105,375) (50,000) (64,610)
Proceeds from disgorgement of short-swing stock profits 907    
Borrowings on line of credit   3,500 73,700
Payments on line of credit   (3,500) (73,700)
Payments related to tax withholding for net-share settled equity awards (809) (316)  
Deferred debt issuance costs     (250)
Net cash provided by (used in) financing activities (105,277) (50,316) (64,860)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (11,140) 11,027 (7,929)
Net increase (decrease) in cash, cash equivalents and restricted cash (33,301) 71,583 32,219
Cash, cash equivalents, and restricted cash at beginning of period 250,535 178,952 146,733
Cash, cash equivalents, and restricted cash at end of period 217,234 250,535 178,952
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets      
Total cash, cash equivalents, and restricted cash 250,535 178,952 146,733
Cash paid during the period for:      
Interest 6 16 323
Income taxes 70,683 46,006 52,579
Cash received during the period for:      
Income tax refund 2,698 4,700  
Non-cash investing activities:      
Credits on notes receivable   86 1,288
Accrued purchases of property and equipment $ 195 $ 109 $ 2,216

Source